miR-124在胃癌中的表达及临床意义

刘　锋; 谢黎明; 张志伟

doi:10.3969/j.issn.1007-3969.2016.03.003

您当前的位置：

首页 >

文章列表页 >

miR-124在胃癌中的表达及临床意义

更新时间：2025-12-31

- miR-124在胃癌中的表达及临床意义
- Expression of miR-124 in gastric cancer and its clinical significance
- 中国癌症杂志 2016年26卷第3期页码：215-220
- 作者机构：
  
  1. 中南大学公共卫生学院,湖南,长沙,430100
  2. 南华大学肿瘤研究所,湖南,衡阳,421001
- 作者简介：
- 基金信息：
  
  国家自然科学基金(31100935);湖南省医药卫生科研基金(B2013-041)。
- DOI：10.3969/j.issn.1007-3969.2016.03.003
  中图分类号：
- 网络出版：2016-06-13，
  
  纸质出版：2016-06-13
- 稿件说明：
移动端阅览
刘　锋,谢黎明,张志伟,等. miR-124在胃癌中的表达及临床意义[J]. 中国癌症杂志, 2016, 26(3): 215-220.

刘　锋, 谢黎明, 张志伟. Expression of miR-124 in gastric cancer and its clinical significance[J]. China Oncology, 2016, 26(3): 215-220.
刘　锋,谢黎明,张志伟,等. miR-124在胃癌中的表达及临床意义[J]. 中国癌症杂志, 2016, 26(3): 215-220. DOI： 10.3969/j.issn.1007-3969.2016.03.003.

刘　锋, 谢黎明, 张志伟. Expression of miR-124 in gastric cancer and its clinical significance[J]. China Oncology, 2016, 26(3): 215-220. DOI： 10.3969/j.issn.1007-3969.2016.03.003.

摘要

背景与目的：miR-124在多种肿瘤中发挥抑癌基因样功能，如肺癌、前列腺癌、膀胱癌和乳腺癌，但是其在胃癌中的表达及临床意义尚不清楚。该研究旨在研究miR-124在正常胃黏膜上皮细胞与不同胃癌细胞及胃癌组织及正常胃黏膜组织中的表达，分析其表达与胃癌患者性别、年龄、组织学分级、T分期、TNM分期、淋巴结转移及预后之间的相关性。方法：采用实时荧光定量聚合酶链反应(real-time fluorescent quantitative polymerase chain-reaction，RTFQ-PCR)检测miR-124在人胃黏膜上皮细胞及胃癌细胞中的表达，采用原位杂交法检测miR-124在胃癌及癌旁正常组织中的表达。结果：RTFQ-PCR结果显示，miR-124在胃癌MKN-74、MKN-28、MKN-45、MGC-803、SGC-7901及AGS细胞中的表达均低于GES-1细胞；原位杂交实验结果显示，miR-124在正常胃黏膜中呈强阳性表达，在胃腺癌组织中表达下降、局灶阳性或缺失；统计分析显示，miR-124与胃腺癌患者组织学分级、TNM分期及淋巴结转移密切相关，与患者的年龄、性别及肿瘤大小无关；Kaplan-Meier生存曲线统计分析显示，miR-124低表达患者的总生存时间和无病生存时间显明低于miR-124高表达患者；多因素分析结果提示，miR-124表达下调是影响患者生存的独立预后因素。结论：miR-124在胃癌细胞及组织中表达下调，并且与患者的组织学分级、TNM分期、淋巴结转移及预后密切相关。

Abstract

Background and purpose: miR-124 is considered to be a tumor suppressor in multiple tumors

including lung cancer

prostate cancer

bladder cancer

and breast cancer. However

its function is unclear in gastric cancer. This study aimed to explore the expression of miR-124 in human gastric mucosal epithelium cells and different gastric cancer cells

as well as gastric cancer tissues and matched para-cancerous tissues. The correlations of miR-124 expression with gender

age

histological grade

T stage

TNM stage

lymph node metastasis and prognosis of gastric cancer patients were analyzed. Methods: A real-time fluorescent quantitative polymerase chain reaction (RTFQ-PCR) was employed for detecting the expression of miR-124 in human gastric mucosal epithelium cells and gastric cancer cells. The expression of miR-124 in gastric cancer tissues and matched para-cancerous tissues was detected by in situ hybridization. Results: The RTFQ-PCR results indicated that the expression of miR-124 was down-regulated in MKN-74

MKN-28

MKN-45

MGC-803

SGC-7901 and AGS cells compared to GES-1 cells. In situ hybridization showed that miR-124 was strongly expressed in normal gastric mucosa. However

low expression

focal positive expression or lack of miR-124 expression were observed in gastric cancer tissues. Statistical analysis showed that miR-124 was closely correlated to histological stage

TNM stage and node metastasis of gastric cancer patients

but not the age

gender and tumor size. The OS and DFS of the patients with low expression of miR-124 were shorter than that of the patients with high expression of miR-124. Multivariate analysis suggested that miR-124 down-regulation was an independent prog-nostic factor for survival in patients with gastric cancer. Conclusion: miR-124 is down-regulated in gastric cancer cells and tissues. The expression of miR-124 is correlated to histological stage

TNM stage

node metastasis and prognosis.

关键词

Keywords

references

浏览量

2599

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

胃癌伴神经内分泌肿瘤与单纯型胃癌的免疫微环境特征比较研究

口服营养补充对胃癌根治术后存在营养风险的老年出院患者影响的前瞻性研究

胃癌领域抗肿瘤药物相关间质性肺病/肺炎的研究进展及展望

基于血清蛋白质组学的TAGLN2、CTSD等5种早期胃癌生物标志物的发现及初步验证

人工智能在胃癌诊疗和患者预后预测中的应用现状及未来展望